Boston Biotech Clinical Research
  • Home
    • SCIO Path to Approval
  • Early Clinical Research
    • Strategy and TPP
    • Translational Medicine and Epigenetics
    • Biologics, Cell and Gene Therapy
    • Real World Evidence
    • Repurposing
  • Orphan Drug Solutions
    • Biomarkers and Surrogate Endpoints
    • Regulatory Affairs FDA and EMA
    • Medical Affairs and Clinical Research
    • Due Diligence
    • Trial Management & Trial Rescue
  • People
    • Senior Advisors
      • Candida Fratazzi
      • Claudio Carini
      • Federico Goodsaid
    • Our Clients
    • Our Collaborators
    • Testimonials
  • Resources
    • BBCR Voice
    • Case Studies
    • Published Studies
    • Conferences & Presentations
    • Job Opportunities
    • Contact Info
Select Page

Rare Disease

Rare Disease

Do Not Make Mistakes!

September 30th, 2019 | Rare Disease

Could Seamless Adaptive Designs Advance Rare Disease Clinical Trial Design?

July 24th, 2019 | Rare Disease

Gene Therapy for Rare Disorders Europe 2019 – October 15th – 17th, London

July 15th, 2019 | Rare Disease

Drug development success hinges on simplifying Clinical Research

May 16th, 2019 | Rare Disease

Strategic Consulting: The convergence revolution to innovate clinical trial process

May 10th, 2019 | Rare Disease

Strategic Consulting – SCIO Process -A New Way for Drug Development

April 30th, 2019 | Rare Disease

Strategic consulting reduces cost and risk of clinical trials

April 2nd, 2019 | Rare Disease

SCIO Helps Early Stage Biotech Company Evaluation

January 24th, 2019 | Rare Disease

Welcome to BBCR’s New Website!

December 7th, 2018 | Rare Disease
Newer posts »

Categories

  • Biomarkers & Surrogate Endpoints
  • Company News
  • Drug Development
  • Due Diligence
  • Early Clinical Development
  • Industry News
  • Medical Affairs and Clinical Research
  • Miscellaneous
  • Orphan Diseases
  • Pre-IND
  • Precision Medicine
  • Rare Disease
  • Real World Evidence
  • Regulatory
  • Regulatory Affairs
  • Strategy and TPP
  • Translation Medicine and Epigenetics
  • Trial Management
  • Trial Rescue

Recent Posts

  • Building a Stronger Path to Market Through Early Clinical Research Strategy
  • Why Early Clinical Research Strategy Is Critical to Successful Drug Development
  • Why Rare Disease Drug Development Requires a Different Clinical Strategy
  • Why do orphan drug launches require specialized strategic planning?
  • BBCR and its consultants are dedicated to advancing innovative and repurposed treatments for orphan diseases, an area where impact is high, but the path is complex.

RSS feed: Nasdaq Globe Newswire Nasdaq Globe Newswire

  • Bioelectronic Medicine - Market Insights, Competitive Landscape, and Market Forecast - 2034 Now Available — Global Market Analysis, Key Players, Product Segments, and Emerging Technologies September 4, 2026
  • Vivani Medical Announces Participation in Upcoming Investor Conferences September 3, 2026
  • Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026 Now Available, Puts Actual SEC-Filed JV Contracts Behind 703 Companies Directly in Reach September 3, 2026
  • Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 September 3, 2026
PRIVACY POLICY
  • LinkedIn

©2026 Boston Biotech Clinical Research. All Rights Reserved.   |   Web Design by Nisse Designs